Novel Subclassification of Presbyopia Based on Lens Functional and Structural Features
Translational Vision Science & Technology · 12.06.2025 · 14 (6) · 26
DOI: 10.1167/tvst.14.6.26 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Translational Vision Science & Technology, erschienen am 12.06.2025. Verfasst von Xiangjia Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Eye Institute and Department of Ophthalmology, Eye & ENT Hospital Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Presbyopia, Lens, Crystalline. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
The purpose of this study was to classify eyes with presbyopia using lens functional and structural features to aid in surgical decision making.
Methods
This cross-sectional observational study included healthy volunteers or those solely affected by presbyopia. Lens function was assessed using dysfunction lens index (DLI), whereas lens density was evaluated with Pentacam (LD-P) and swept-source optical coherence tomography (LD-S). Principal component analysis (PCA) and k-means clustering classified participants into non-lens surgery (NLS) and lens surgery (LS) groups. A scoring system was developed from the optimal cutoff values for simplified diagnosis, with a website created for automatic classification.
Results
Totally, 352 eyes of 176 patients were studied, with a mean age of 46.1 ± 6.2 years and a mean axial length of 24.42 ± 1.62 mm. Among them, 268 (76.1%) eyes were diagnosed with presbyopia. The top 5.2% (14/268) of presbyopia cases with the highest variability were excluded by PCA. Subsequently, 138 eyes (51.5%) were clustered into the NLS group, and 116 eyes (43.3%) into the LS group. The LS group presented lower DLI and higher lens density compared to the NLS group (all P < 0.001). Optimal cutoff values were determined as follows: DLI = 7.75, LD-P = 8.75, and LD-S = 60.05 pixel units. The scoring system demonstrated that combining DLI with LD-P achieved the highest diagnostic efficacy. A website (www.zhu-zhou-lf.com) was developed for automatic classification.
Conclusions
We proposed a novel classification of presbyopia using lens functional and structural features. Translational Relevance: This classification, integrating DLI and lens density values, offers a diagnostic tool to guide surgical decisions in presbyopia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Eye Institute and Department of Ophthalmology, Eye & ENT Hospital Fudan University, Shanghai, China.
- NHC Key laboratory of Myopia and Related Eye Diseases, Key Laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical Sciences, Shanghai, China.
- Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China.
- Cataract and Lens Refractive Surgery Group, Eye Institute, Eye & ENT Hospital, Fudan University, Shanghai, China.
- Shanghai Research Center of Ophthalmology and Optometry, Shanghai, China.
- Shanghai Engineering Research Center of Laser and Autostereoscopic 3D for Vision Care, Shanghai, China.
Zitieren
APA
Zhu, X., Liu, X., He, W., Cheng, K., Meng, J., Qi, J., Zhao, J., Lu, Y., & Zhou, X. (2025). Novel Subclassification of Presbyopia Based on Lens Functional and Structural Features. Translational Vision Science & Technology, 14(6), 26. https://doi.org/10.1167/tvst.14.6.26
Vancouver
Zhu X, Liu X, He W, Cheng K, Meng J, Qi J, et al. Novel Subclassification of Presbyopia Based on Lens Functional and Structural Features. Translational Vision Science & Technology. 2025;14(6):26. doi:10.1167/tvst.14.6.26
BibTeX
@article{Zhu2025,
author = {Zhu, Xiangjia and Liu, Xin and He, Wenwen and Cheng, Kaiwen and Meng, Jiaqi and Qi, Jiao and Zhao, Jing and Lu, Yi and Zhou, Xingtao},
title = {Novel Subclassification of Presbyopia Based on Lens Functional and Structural Features},
journal = {Translational Vision Science & Technology},
year = {2025},
volume = {14},
number = {6},
pages = {26},
doi = {10.1167/tvst.14.6.26}
}
EUVIMED